NCT07631130

Brief Summary

The goal of this clinical trial is to learn if pre-walking infants with Down syndrome can use a suspension walker in their home and community environments. The main questions it aims to answer are:

  • Is suspension walker intervention feasible for pre-walking infants with Down syndrome?
  • What are barriers to successfully using suspension walkers in home and community environments?
  • What are facilitators for successfully using suspension walkers in home and community environments? Participants will:
  • Use a suspension walker in the home and community for a three-month period (goal 20 minutes/day, 5 days/week)
  • Meet with a therapist three times in their home to learn how to use the walker
  • Track how often they use the walker for one week each month
  • Complete assessments of infants' gross motor skill and ability to use the walker before and after the three-month period
  • Be interviewed after the three-month period about their experiences using the walker

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
23mo left

Started Sep 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 5, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

June 5, 2026

Status Verified

June 1, 2026

Enrollment Period

1.9 years

First QC Date

May 28, 2026

Last Update Submit

June 2, 2026

Conditions

Keywords

Down syndromeinfantmobility devicewalkerwalkingearly intervention

Outcome Measures

Primary Outcomes (1)

  • participation in instructed dosage

    Dichotomous: Was the family able to use the walker for the instructed 20 minutes/day, 5 days/week?

    first week of each month for three months

Secondary Outcomes (5)

  • usage frequency and duration

    first week of each month for three months

  • steps per minute

    first week of each month for three months

  • gross motor function

    0 and 3 months

  • stepping ability

    0 and 3 months

  • walker propulsion

    0 and 3 months

Study Arms (1)

walker intervention

EXPERIMENTAL

walker intervention

Behavioral: suspension walker

Interventions

Parents will be provided with a pediatric suspension walker and instructed to use the walker with their infant at least 20 total min/day, 5 days/week. Parents will be instructed in 3 activity types: 1) Adult-propelled stepping consists of the caregiver moving the walker along the floor to prompt the infant to step. 2) Self-propelled walking consists of encouraging the infant to step independently to propel the walker, with intermittent assistance from the caregiver as needed. 3) Play consists of a variety of mobile and stationary play activities, adapted to the child's interests, engaged in while supported in the walker. Parents will brainstorm with the therapist to select play activities and to determine where and when to perform stepping and walking activities. This may include home- and community-based locations, including larger rooms in the home, hallways, sidewalks, parks, and indoor community spaces like supermarkets or shopping malls.

walker intervention

Eligibility Criteria

Age10 Months - 13 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of Down syndrome
  • months of age
  • Able to sit independently
  • Unable to walk independently

You may not qualify if:

  • Medical or orthopedic conditions other than Down syndrome that prevent standing or walking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Down Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Officials

  • Kari S Kretch, PT, DPT, PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kari S Kretch

CONTACT

Learning, Development, and Rehabilitation Lab

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 28, 2026

First Posted

June 5, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

June 5, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

all non-identifiable IPD

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
at the time of publication of results